AGAndrew L. Gilbert

Andrew L. Gilbert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrew L. Gilbert has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans

    by Elizabeth E Roughead, Lisa M Kalisch Ellett, Emmae N Ramsay, Nicole L Pratt, John D Barratt, Vanessa T LeBlanc, Philip Ryan, Robert Peck, Graeme Killer, Andrew L Gilbert

    Background: The Australian Government Department of Veterans’ Affairs (DVA) funds an ongoing health promotion based program to improve use of medicines and related health services, which implements interventions that include audit and feedback in the form of patient-specific feedback generated from administrative claims records. We aimed to determine changes in medicine use as a result of the program. Methods: The program provides targeted patient-specific feedback to medical practitioners. The feedback is supported with educational material developed by a clinical panel, subject to peer review and overseen by a national editorial committee. Veterans who meet target criteria also receive educational brochures. The program is supported by a national call centre and ongoing national consultation. Segmented regression analyses (interrupted time series) were undertaken to assess changes in medication use in targeted veterans pre and post each intervention. Results: 12 interventions were included; three to increase medicine use, seven which aimed to reduce use, and two which had combination of messages to change use. All programs that aimed to increase medicine use were effective, with relative effect sizes at the time of the intervention ranging from 1% to 8%. Mixed results were seen with programs aiming to reduce inappropriate medicine use. Highly specific programs were effective, with relative effect sizes at the time of the intervention of 10% decline in use of NSAIDs in high risk groups and 14% decline in use of antipsychotics in dementia. Interventions targeting combinations of medicines, including medicine interactions and potentially inappropriate medicines in the elderly did not change practice significantly. Interventions with combinations of messages targeting multiple components of practice had an impact on one component, but not all components targeted. Conclusions: The Veterans’ MATES program showed positive practice change over time, with interventions increasing use of appropriate medicines where under-use was evident and reduced use of inappropriate medicines when single medicines were targeted. Combinations of messages were less effective, suggesting specific messages focusing on single medicines are required to maximise effect. The program provides a model that could be replicated in other settings.


  • Open Access

    Transient ischaemic attack and ischaemic stroke: constructing episodes of care using hospital claims data

    by Janet K Sluggett, Gillian E Caughey, Michael B Ward, Elizabeth E Roughead, Andrew L Gilbert

    Stroke patients may have multiple hospital separations relating to the same stroke. Understanding the pattern of hospitalisations for these patients enables first and recurrent events to be distinguished to better understand care. The aim of this study was to investigate reasons for hospital separations after transient ischaemic attack (TIA) or ischaemic stroke and construct episode of care criteria.


  • Open Access

    Providing community-based health practitioners with timely and accurate discharge medicines information

    by Alice V Gilbert, Bhavini Patel, Melanie Morrow, Desmond Williams, Michael S Roberts, Andrew L Gilbert

    Accurate and timely medication information at the point of discharge is essential for continuity of care. There are scarce data on the clinical significance if poor quality medicines information is passed to the next episode of care. This study aimed to compare the number and clinical significance of medication errors and omission in discharge medicines information, and the timeliness of delivery of this information to community-based health practitioners, between the existing Hospital Discharge Summary (HDS) and a pharmacist prepared Medicines Information Transfer Fax (MITF).


  • The Australian pharmacist workforce: employment status, practice profile and job satisfaction

    by Vivienne S. L. Mak, Alice Clark, Geoff March, Andrew L. Gilbert

    Objective.: The aims were to determine Australian registered pharmacists’ current employment status, practice profile and professional satisfaction. Method.: A questionnaire was mailed to all registered pharmacists (n = 7764) on the Pharmacy Boards of Victoria and South Australia’s registers; 19 were returned undeliverable. Quantitative data were entered and analysed using the Statistical Package for Social Sciences Version 17. Qualitative data were subjected to a thematic analysis. Results.: 1627 (21%) pharmacists responded: 259 (16%) were registered as pharmacists but no longer worked in the pharmacy profession. A total of 1366 respondents reported still working as pharmacists. Of the 1366, 912 (67%) indicated that they spend most of their time in a clinical area; 233 (17%) spend most of their time in ‘non-clinical pharmacist work (i.e. dispensing as technical supply)’; 216 (16%) worked in other non-clinical roles and; 1053 (77%) were professionally satisfied. Conclusion.: Measuring the pharmacist workforce based on registration data significantly overestimates the available clinical pharmacist workforce: 708 (44%) respondents were no longer working in the profession, were not mainly involved in clinical practice or were working in non-clinical roles. A significant re-professionalisation program is needed if pharmacists’ unique knowledge and skills are to contribute to better healthcare delivery. What is known about the topic?: A well trained and sufficient workforce is an essential requirement if the objectives of Australia’s healthcare reform agenda are to be met. For the pharmacy profession, a change in practice profile of pharmacists from a product supply focus to a patient care focus is also required. Recent workforce studies have used pharmacist registration data to model the supply of pharmacists. What does this paper add?: This paper reports on a survey of registered pharmacists to more closely examine the available pharmacist workforce. The insights into the current employment status and practice profile of pharmacists provide an understanding of the available clinical pharmacist workforce. What are the implications for practitioners?: Previous workforce modelling may seriously overestimate the ‘available’ pharmacist workforce to meet the needs of the community as the health reform agenda rolls out. Strategies are needed to retain pharmacists within the pharmacy profession, and to attract and retain pharmacists in clinical roles.


  • Chronic disease management: does the disease affect likelihood of care planning?

    by Agnes I. Vitry, Elizabeth E. Roughead, Emmae N. Ramsay, Philip Ryan, Gillian E. Caughey, Adrian Esterman, Sepehr Shakib, Andrew L. Gilbert, Robyn McDermott

    Objective.: To compare the demographic, socioeconomic, and medical characteristics of patients who had a General Practitioner Management Plan (GPMP) with those for patients without GPMP. Methods.: Cohort study of patients with chronic diseases during the time period 1 July 2006 to 30 June 2008 using the Australian Department of Veterans’ Affairs (DVA) claims database. Results.: Of the 88 128 veterans with chronic diseases included in the study, 23 015 (26%) veterans had a GPMP and 11 089 (13%) had a Team Care Arrangement (TCA). Those with a GPMP had a higher number of comorbidities (P < 0.001), and a higher use of services such as health assessment and medicine review (P < 0.001) than did those without GPMP. Diabetes was associated with a significantly increased use of GPMP compared with all other chronic diseases except heart failure. Conclusions.: GPMPs are used in a minority of patients with chronic diseases. Use is highest in people with diabetes. What is known about the topic?: Despite the fact that the Chronic Disease Management (CDM) program is appreciated by patients and allied health professionals, limited research has assessed how it is used in practice. What does this paper add?: In the Veteran population, use of a General Practitioner Management Plan (GPMP) was associated with a higher number of comorbidities and of prior hospitalisations. Across chronic diseases use of GPMPs was low but was higher in people with diabetes. What are the implications for practitioners?: Further research into the effect of CDM program on improvement of health outcomes is required.


  • Open Access

    Ageing well: Improving the management of patients with multiple chronic health problems

    by Andrew L Gilbert, Gillian E Caughey, Agnes I Vitry, Alice Clark, Philip Ryan, Robyn A McDermott, Sepehr Shakib, Mary A Luszcz, Adrian Esterman, Elizabeth E Roughead

    Aim:  To identify and evaluate the management and care of older people with multiple chronic health problems (MCHP).Methods:  Administrative health data from the Department of Veterans' Affairs and bio‐social data from the Australian Longitudinal Study of Ageing are used to determine prevalence of MCHP, treatment patterns and patient outcomes. Focus groups and semistructured interviews are used to gain patient and health practitioner perspectives.Results:  The prevalence of MCHP in older people is high (65%) and is associated with increased use of health services, mortality and poorer self‐rated health. Australian disease‐specific guidelines fail to address MCHP, and treatment conflicts with the potential to cause harm, were common.Conclusion:  Improvements in the care and management of older people with MCHP requires: a multifaceted approach, across the health‐care system; better coordination of holistic, patient‐centred multidisciplinary care; and effective communication and education of all stakeholders. The Health reform agenda in Australia provides an opportunity for change.


  • Open Access

    Use of health services and medicines amongst Australian war veterans: a comparison of young elderly, near centenarians and centenarians

    by Elizabeth E Roughead, Lisa M Kalisch, Emmae N Ramsay, Philip Ryan, Andrew L Gilbert

    Age and life expectancy of residents in many developed countries, including Australia, is increasing. Health resource and medicine use in the very old is not well studied. The purpose of this study was to identify annual use of health services and medicines by very old Australian veterans; those aged 95 to 99 years (near centenarians) and those aged 100 years and over (centenarians). The study population included veterans eligible for all health services subsidised by the Department of Veterans' Affairs (DVA) aged 95 years and over at August 1st 2006. A cohort of veterans aged 65 to 74 years was identified for comparison. Data were sourced from DVA claims databases. We identified all claims between August 1st 2006 and July 31st 2007 for medical consultations, pathology, diagnostic imaging and allied health services, hospital admissions, number of prescriptions and unique medicines. Chi squared tests were used to compare the proportion of centenarians (those aged 100 years and over) and near centenarians (those aged 95 to 99 years) who accessed medicines and health services with the 65 to 74 year age group. For those who accessed health services during follow up, Poisson regression was used to compare differences in the number of times centenarians and near centenarians accessed each health service compared to 65 to 74 year olds. A similar proportion (98%) of centenarians and near centenarians compared to those aged 65 to 74 consulted a GP and received prescription medicine during follow up. A lower proportion of centenarians and near centenarians had claims for specialist visits (36% and 57% respectively), hospitalisation (19% and 24%), dental (12% and 18%), physiotherapy (13% and 15%), pathology(68% and 78%) and diagnostic imaging services (51% and 68%) (p < 0.0001) and a higher proportion had claims for care plans (19% and 25%), occupational therapy (15% and 17%) and podiatry services (54% and 58%) (p < 0.0001). Compared to those aged 65 to 74, a lower proportion of centenarians and near centenarians received antihypertensives, lipid lowering therapy, antiinflammatories, and antidepressants (p < 0.0001) and a higher proportion received antibiotics, analgesics, diuretics, laxatives, and anti-anaemics (p < 0.0001). Medical consultations and medicines are the health services most frequently accessed by Australian veteran centenarians and near centenarians. For most health services, the proportion of very old people who access them is similar to or less than younger elderly. Our results support the findings of other studies which suggest that longevity is not necessarily associated with excessive health service use.


  • Provision of medicines information in Australian community pharmacies

    by Agnes Vitry, Andrew Gilbert, Kathy Mott, Deepa Rao, Geoff March

    Objective To assess the provision of consumer medicines information in Australian community pharmacies. Method Two methods were employed. One was an exit survey involving consumers just leaving a community pharmacy (n = 554). A total of 42 pharmacies from 6 states were selected randomly. Another was a telephone survey conducted with people aged 15 and over (n = 2,005). The sample was stratified by region at the level of capital city, regional urban and rural with minimum quotas for each category. Results In the exit survey, 13 (6.4%) of the 208 respondents collecting a script received written instructions such as the Consumer Medicines Information (CMI), including 7 (15%) receiving their prescription for the first time and 6 (4%) who came for a subsequent supply. In the phone survey, 876 (46%)of the 1,576 respondents who ever get prescriptions or OTC medicines declared they never or rarely receive written information on how to use a medicine apart from what is on the bottle or packaging. Conclusion The strategy of CMI distribution via pharmacies in Australia has failed to reach acceptable levels. Further strategies have to be implemented by the professional and consumer organisations to ensure consumers receive appropriate essential medicine information.